Here the authors provide exploratory analyses of a clinical trial evaluating immunogenicity of inactivated and mRNA SARS-CoV-2 vaccines, and show that CoronaVac primed groups have disparate T cell responses and nucleocapsid specific antibodies compared to BNT162b2 that may protect in the absence of robust neutralizing antibody responses.
All Keywords
【저자키워드】 Adaptive immunity, Vaccines,
【저자키워드】 Adaptive immunity, Vaccines,